Tabalumab MedChemExpress (MCE)

Product Name	Tabalumab
Synonyms	Tabalumab
CAS	1143503-67-6
EINECS
Chemical Formula
Molecular Weight
inchi
Package	1 mg;5 mg;10 mg
Price	Email to quote
Descriptions	Tabalumab Tabalumab MedChemExpress (MCE) HY-P99220 1143503-67-6 LY2127399 98.11% Please store the product under the recommended conditions in the Certificate of Analysis. Shipping with dry ice. Tabalumab (LY2127399) is a human anti-BAFF (B-cell activating factor) monoclonal antibody (IgG4 type) with neutralising activity against membrane bound and soluble BAFF. Tabalumab can be used in studies of autoimmune diseases such as rheumatoid arthritis, renal failure and systemic lupus erythematosus. Tabalumab (1-100 ng/mL Descriptions Tabalumab Tabalumab MedChemExpress (MCE) HY-P99220 1143503-67-6 LY2127399 98.11% Please store the product under the recommended conditions in the Certificate of Analysis. Shipping with dry ice. Tabalumab (LY2127399) is a human anti-BAFF (B-cell activating factor) monoclonal antibody (IgG4 type) with neutralising activity against membrane bound and soluble BAFF. Tabalumab can be used in studies of autoimmune diseases such as rheumatoid arthritis, renal failure and systemic lupus erythematosus. Tabalumab (1-100 ng/mL 44 h) neutralizes soluble and membrane-bound BaFF both in T1165.17 cells and (1 μg/mL 3 days) CD19+ B-cells[1]. Tabalumab (50 μg/mL 15 min) inhibits BaFF binding to BR3, TacI, and BcMa in HEK293 cells[1]. Tabalumab (500 μg/rat s.c. single) leads to decreased B-cells and a reduction in non-canonical nF-κB signaling[1]. BAFF[1]. In Vitro Tabalumab (1-100 ng/mL 44 h) neutralizes soluble and membrane-bound BaFF both in T1165.17 cells and (1 μg/mL 3 days) CD19+ B-cells[1]. Tabalumab (50 μg/mL 15 min) inhibits BaFF binding to BR3, TacI, and BcMa in HEK293 cells[1]. MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only. 0 --> Tabalumab Related Antibodies Cell Viability Assay[1] Cell Line: T1165.17 cells Human Human IgG4 kappa Human IgG4 (S228P) kappa, Isotype Control \| \| \| \| \| \| \| \| \| \| [1]. Manetta J, et al. Generation and characterization of tabalumab, a human monoclonal antibody that neutralizes both soluble and membrane-bound B-cell activating factor. J Inflamm Res. 2014 Aug 20 7:121-31. [Content Brief]
Last Update	2025-04-01 14:45:47

MedChemExpress (MCE) also provides

Depatuxizumab

Category: Inhibitory Antibodies
CAS: 1471999-69-5
Last Update: 2025-04-01 14:45:47

Raxibacumab

Category: Inhibitory Antibodies
CAS: 565451-13-0
Last Update: 2025-04-01 14:45:47

Crizanlizumab

Category: Inhibitory Antibodies
CAS: 1690318-25-2
Last Update: 2025-04-01 14:45:47

Sofituzumab vedotin

Category: Inhibitory Antibodies
CAS: 1418200-58-4
Last Update: 2025-04-01 14:45:47

Fazpilodemab

Category: Inhibitory Antibodies
CAS: 2517935-02-1
Last Update: 2025-04-01 14:45:47

Osemitamab

Category: Inhibitory Antibodies
CAS: 2460539-61-9
Last Update: 2025-04-01 14:45:47

Visugromab

Category: Inhibitory Antibodies
CAS: 2556646-63-8
Last Update: 2025-04-01 14:45:47

Vobramitamab

Category: Inhibitory Antibodies
CAS: 2490556-50-6
Last Update: 2025-04-01 14:45:47


Supplier Name	MedChemExpress (MCE)
Contact	sales
Tel	609-228-6898
Mobile	609-228-6898
QQ
Email	sales@medchemexpress.com; tech@medchemexpress.com
Website	https://www.medchemexpress.com/
Wechat

Request for quotation

Supplier Contact